Share Price and Basic Stock Data
Last Updated: December 5, 2025, 8:10 pm
| PEG Ratio | -3.37 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Morganite Crucible (India) Ltd operates in the refractories sector, primarily serving industries that require high-temperature materials. The company has shown a steady upward trajectory in sales, reporting ₹155 Cr for the fiscal year ending March 2023, up from ₹152 Cr the previous year. This growth reflects a resilient demand for refractories, with the latest quarterly figures indicating sales of ₹45.35 Cr in September 2023, a notable improvement from ₹33.98 Cr in the preceding quarter. The company’s ability to maintain sales momentum, particularly during a period of fluctuating market conditions, suggests strong operational capabilities and effective market positioning. Furthermore, the trailing twelve months (TTM) revenue stands at ₹174 Cr, which aligns with the increasing trend observed over the past few years. This consistent performance is crucial for stakeholders as it reflects the underlying strength of the business model amidst competitive pressures in the industry.
Profitability and Efficiency Metrics
Profitability metrics for Morganite Crucible present a robust picture, with an operating profit margin (OPM) of 21.46% reported for the latest quarter. This is indicative of efficient cost management and effective pricing strategies, especially when compared to the OPM of 16% in FY 2023. The net profit for the same quarter was ₹8.31 Cr, contributing to a year-to-date net profit of ₹16 Cr, underscoring the company’s capacity to convert revenue into profit efficiently. Additionally, the return on equity (ROE) stood at an impressive 21.4%, showcasing the company’s ability to generate substantial returns for shareholders. However, the interest coverage ratio (ICR) of 0.00x indicates that the company is operating without debt, which could limit its leverage for growth but also reduces financial risk. Overall, these profitability metrics suggest that Morganite Crucible is well-positioned to sustain its margins and profitability in the coming quarters.
Balance Sheet Strength and Financial Ratios
Morganite Crucible’s balance sheet appears solid, with total borrowings reported at a mere ₹2 Cr, reflecting a conservative financial approach. The company’s reserves have grown to ₹133 Cr, which provides a cushion for future investments and operational needs. The price-to-book value ratio (P/BV) is pegged at 2.83x, which may seem elevated compared to traditional benchmarks, yet it indicates a market perception of growth potential. Furthermore, the cash conversion cycle (CCC) of only 2 days demonstrates efficient working capital management, enhancing liquidity. The return on capital employed (ROCE) of 30.4% stands out, indicating that the company is effectively utilizing its capital to generate profits. While the low debt levels minimize financial risk, they also present a challenge in terms of leveraging growth opportunities that may require additional capital investment.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Morganite Crucible reveals a strong promoter holding of 75%, which is a positive indicator of management confidence in the company’s future. The public holding stands at around 23.70%, with foreign institutional investors (FIIs) at a modest 0.18% and domestic institutional investors (DIIs) at 1.13%. This distribution suggests limited institutional interest, which could be a double-edged sword; while it reflects a strong promoter commitment, it also indicates potential challenges in attracting broader institutional investment. The number of shareholders has steadily increased, reaching 7,455, showcasing growing retail interest. This could be a sign of increasing confidence in the company’s operational performance and financial health, suggesting that investors are optimistic about its long-term prospects.
Outlook, Risks, and Final Insight
Looking ahead, Morganite Crucible faces a landscape filled with both opportunities and challenges. The ongoing demand for refractories, driven by sectors such as steel and cement, is a significant growth driver. However, the company must navigate potential risks such as rising raw material costs and supply chain disruptions, which could impact profit margins. Additionally, while the lack of debt provides financial stability, it may also limit growth if not strategically managed. Investors should consider the implications of a conservative capital structure, especially in a capital-intensive industry. Overall, while Morganite Crucible demonstrates strong fundamentals, potential investors must weigh these strengths against the broader market dynamics and operational risks to make informed decisions about their investment in this stock.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Morganite Crucible (India) Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Morganite Crucible (India) Ltd | 864 Cr. | 1,544 | 1,964/1,170 | 34.2 | 242 | 3.17 % | 30.4 % | 21.4 % | 5.00 |
| Associated Ceramics Ltd | 69.4 Cr. | 231 | 299/177 | 21.6 | 86.2 | 0.00 % | 10.8 % | 9.55 % | 10.0 |
| Vesuvius India Ltd | 9,746 Cr. | 480 | 647/356 | 40.0 | 75.0 | 0.30 % | 25.5 % | 19.3 % | 1.00 |
| IFGL Refractories Ltd | 1,469 Cr. | 204 | 340/163 | 49.4 | 158 | 1.72 % | 5.71 % | 3.94 % | 10.0 |
| Industry Average | 4,026.33 Cr | 614.75 | 36.30 | 140.30 | 1.30% | 18.10% | 13.55% | 6.50 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 40.27 | 38.85 | 41.49 | 33.98 | 42.69 | 45.35 | 40.00 | 39.90 | 42.90 | 44.31 | 44.66 | 42.32 | 42.54 |
| Expenses | 33.75 | 31.94 | 33.43 | 30.23 | 31.19 | 32.51 | 31.50 | 34.28 | 32.12 | 31.48 | 34.18 | 35.77 | 33.41 |
| Operating Profit | 6.52 | 6.91 | 8.06 | 3.75 | 11.50 | 12.84 | 8.50 | 5.62 | 10.78 | 12.83 | 10.48 | 6.55 | 9.13 |
| OPM % | 16.19% | 17.79% | 19.43% | 11.04% | 26.94% | 28.31% | 21.25% | 14.09% | 25.13% | 28.96% | 23.47% | 15.48% | 21.46% |
| Other Income | 1.15 | 0.23 | 1.82 | 1.64 | 1.15 | 1.12 | 2.83 | -2.20 | 1.96 | 1.75 | 2.75 | 1.52 | 2.11 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.06 | 0.03 | 0.08 | 0.08 | 0.05 | 0.03 | 0.04 |
| Depreciation | 1.77 | 1.94 | 2.02 | 2.03 | 2.04 | 2.21 | 2.11 | 2.09 | 1.95 | 2.17 | 2.31 | 2.62 | 2.77 |
| Profit before tax | 5.90 | 5.20 | 7.86 | 3.36 | 10.61 | 11.71 | 9.16 | 1.30 | 10.71 | 12.33 | 10.87 | 5.42 | 8.43 |
| Tax % | 26.61% | 25.00% | 24.94% | 40.77% | 26.48% | 29.04% | 27.07% | 46.92% | 26.33% | 27.74% | 27.78% | 46.86% | 31.55% |
| Net Profit | 4.33 | 3.91 | 5.90 | 1.99 | 7.80 | 8.31 | 6.67 | 0.70 | 7.90 | 8.92 | 7.85 | 2.88 | 5.77 |
| EPS in Rs | 7.73 | 6.98 | 10.54 | 3.55 | 13.93 | 14.84 | 11.91 | 1.25 | 14.11 | 15.93 | 14.02 | 5.14 | 10.30 |
Last Updated: August 19, 2025, 1:05 pm
Below is a detailed analysis of the quarterly data for Morganite Crucible (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 42.54 Cr.. The value appears strong and on an upward trend. It has increased from 42.32 Cr. (Mar 2025) to 42.54 Cr., marking an increase of 0.22 Cr..
- For Expenses, as of Jun 2025, the value is 33.41 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 35.77 Cr. (Mar 2025) to 33.41 Cr., marking a decrease of 2.36 Cr..
- For Operating Profit, as of Jun 2025, the value is 9.13 Cr.. The value appears strong and on an upward trend. It has increased from 6.55 Cr. (Mar 2025) to 9.13 Cr., marking an increase of 2.58 Cr..
- For OPM %, as of Jun 2025, the value is 21.46%. The value appears strong and on an upward trend. It has increased from 15.48% (Mar 2025) to 21.46%, marking an increase of 5.98%.
- For Other Income, as of Jun 2025, the value is 2.11 Cr.. The value appears strong and on an upward trend. It has increased from 1.52 Cr. (Mar 2025) to 2.11 Cr., marking an increase of 0.59 Cr..
- For Interest, as of Jun 2025, the value is 0.04 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.03 Cr. (Mar 2025) to 0.04 Cr., marking an increase of 0.01 Cr..
- For Depreciation, as of Jun 2025, the value is 2.77 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.62 Cr. (Mar 2025) to 2.77 Cr., marking an increase of 0.15 Cr..
- For Profit before tax, as of Jun 2025, the value is 8.43 Cr.. The value appears strong and on an upward trend. It has increased from 5.42 Cr. (Mar 2025) to 8.43 Cr., marking an increase of 3.01 Cr..
- For Tax %, as of Jun 2025, the value is 31.55%. The value appears to be improving (decreasing) as expected. It has decreased from 46.86% (Mar 2025) to 31.55%, marking a decrease of 15.31%.
- For Net Profit, as of Jun 2025, the value is 5.77 Cr.. The value appears strong and on an upward trend. It has increased from 2.88 Cr. (Mar 2025) to 5.77 Cr., marking an increase of 2.89 Cr..
- For EPS in Rs, as of Jun 2025, the value is 10.30. The value appears strong and on an upward trend. It has increased from 5.14 (Mar 2025) to 10.30, marking an increase of 5.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 12:52 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 81 | 89 | 89 | 111 | 109 | 120 | 129 | 107 | 152 | 155 | 168 | 174 | 174 |
| Expenses | 64 | 70 | 68 | 83 | 86 | 100 | 111 | 96 | 122 | 129 | 129 | 133 | 135 |
| Operating Profit | 17 | 18 | 20 | 29 | 23 | 20 | 17 | 10 | 30 | 25 | 39 | 41 | 39 |
| OPM % | 21% | 21% | 23% | 26% | 21% | 17% | 13% | 10% | 20% | 16% | 23% | 24% | 22% |
| Other Income | 2 | 0 | 2 | 2 | 3 | 6 | 7 | 1 | 32 | 5 | 3 | 8 | 8 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 5 | 8 | 7 | 5 | 4 | 4 | 5 | 6 | 7 | 8 | 8 | 9 | 10 |
| Profit before tax | 13 | 11 | 16 | 26 | 21 | 22 | 18 | 6 | 54 | 22 | 33 | 39 | 37 |
| Tax % | 37% | 44% | 36% | 37% | 35% | 30% | 29% | 116% | 20% | 28% | 28% | 30% | |
| Net Profit | 8 | 6 | 10 | 17 | 14 | 15 | 13 | -1 | 43 | 16 | 23 | 28 | 25 |
| EPS in Rs | 15.04 | 10.75 | 17.64 | 29.64 | 24.79 | 27.45 | 23.43 | -1.66 | 77.48 | 28.79 | 41.95 | 49.18 | 45.39 |
| Dividend Payout % | 3% | 5% | 11% | 13% | 32% | 29% | 34% | 0% | 70% | 69% | 95% | 100% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -25.00% | 66.67% | 70.00% | -17.65% | 7.14% | -13.33% | -107.69% | 4400.00% | -62.79% | 43.75% | 21.74% |
| Change in YoY Net Profit Growth (%) | 0.00% | 91.67% | 3.33% | -87.65% | 24.79% | -20.48% | -94.36% | 4507.69% | -4462.79% | 106.54% | -22.01% |
Morganite Crucible (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 6% |
| 3 Years: | 5% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 16% |
| 3 Years: | -7% |
| TTM: | -1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 12% |
| 3 Years: | 20% |
| 1 Year: | -6% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 17% |
| 3 Years: | 18% |
| Last Year: | 21% |
Last Updated: September 5, 2025, 3:51 pm
Balance Sheet
Last Updated: December 4, 2025, 3:07 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves | 53 | 58 | 67 | 77 | 88 | 96 | 105 | 100 | 120 | 124 | 126 | 129 | 133 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 |
| Other Liabilities | 27 | 14 | 18 | 38 | 23 | 28 | 32 | 37 | 32 | 34 | 45 | 37 | 27 |
| Total Liabilities | 82 | 75 | 88 | 118 | 114 | 127 | 139 | 139 | 155 | 161 | 174 | 170 | 164 |
| Fixed Assets | 23 | 18 | 15 | 25 | 27 | 31 | 32 | 30 | 38 | 53 | 62 | 81 | 83 |
| CWIP | 0 | 1 | 3 | 2 | 0 | 4 | 19 | 22 | 15 | 1 | 0 | 4 | 2 |
| Investments | 5 | 5 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 54 | 51 | 65 | 91 | 87 | 93 | 88 | 87 | 102 | 106 | 112 | 86 | 80 |
| Total Assets | 82 | 75 | 88 | 118 | 114 | 127 | 139 | 139 | 155 | 161 | 174 | 170 | 164 |
Below is a detailed analysis of the balance sheet data for Morganite Crucible (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Reserves, as of Sep 2025, the value is 133.00 Cr.. The value appears strong and on an upward trend. It has increased from 129.00 Cr. (Mar 2025) to 133.00 Cr., marking an increase of 4.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 27.00 Cr.. The value appears to be improving (decreasing). It has decreased from 37.00 Cr. (Mar 2025) to 27.00 Cr., marking a decrease of 10.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 164.00 Cr.. The value appears to be improving (decreasing). It has decreased from 170.00 Cr. (Mar 2025) to 164.00 Cr., marking a decrease of 6.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 83.00 Cr.. The value appears strong and on an upward trend. It has increased from 81.00 Cr. (Mar 2025) to 83.00 Cr., marking an increase of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 80.00 Cr.. The value appears to be declining and may need further review. It has decreased from 86.00 Cr. (Mar 2025) to 80.00 Cr., marking a decrease of 6.00 Cr..
- For Total Assets, as of Sep 2025, the value is 164.00 Cr.. The value appears to be declining and may need further review. It has decreased from 170.00 Cr. (Mar 2025) to 164.00 Cr., marking a decrease of 6.00 Cr..
Notably, the Reserves (133.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 17.00 | 18.00 | 20.00 | 29.00 | 23.00 | 20.00 | 17.00 | 10.00 | 30.00 | 25.00 | 38.00 | 40.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 50 | 59 | 60 | 57 | 52 | 66 | 76 | 75 | 64 | 58 | 65 |
| Inventory Days | 156 | 142 | 149 | 158 | 179 | 159 | 158 | 143 | 136 | 124 | 116 | 100 |
| Days Payable | 232 | 116 | 119 | 129 | 176 | 161 | 145 | 178 | 154 | 146 | 185 | 164 |
| Cash Conversion Cycle | -15 | 75 | 89 | 89 | 60 | 49 | 78 | 41 | 57 | 42 | -11 | 2 |
| Working Capital Days | 41 | 69 | 67 | 5 | 60 | 44 | 62 | 33 | 71 | 48 | 16 | 39 |
| ROCE % | 27% | 19% | 24% | 36% | 25% | 23% | 18% | 8% | 39% | 18% | 28% | 30% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 51.87 | 35.67 | 20.57 | 30.16 | 34.37 |
| Diluted EPS (Rs.) | 51.87 | 35.67 | 20.57 | 30.16 | 34.37 |
| Cash EPS (Rs.) | 75.38 | 66.81 | 52.61 | 51.15 | 55.75 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 343.51 | 285.76 | 253.44 | 234.62 | 204.61 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 343.51 | 285.76 | 253.44 | 234.62 | 204.61 |
| Revenue From Operations / Share (Rs.) | 397.75 | 392.35 | 393.06 | 360.68 | 357.27 |
| PBDIT / Share (Rs.) | 109.55 | 95.26 | 71.70 | 72.15 | 81.96 |
| PBIT / Share (Rs.) | 91.91 | 65.59 | 39.72 | 52.18 | 65.20 |
| PBT / Share (Rs.) | 91.91 | 65.59 | 39.70 | 50.95 | 65.06 |
| Net Profit / Share (Rs.) | 57.74 | 37.14 | 20.62 | 31.18 | 38.99 |
| NP After MI And SOA / Share (Rs.) | 51.87 | 35.67 | 20.57 | 30.16 | 34.37 |
| PBDIT Margin (%) | 27.54 | 24.28 | 18.24 | 20.00 | 22.94 |
| PBIT Margin (%) | 23.10 | 16.71 | 10.10 | 14.46 | 18.25 |
| PBT Margin (%) | 23.10 | 16.71 | 10.09 | 14.12 | 18.20 |
| Net Profit Margin (%) | 14.51 | 9.46 | 5.24 | 8.64 | 10.91 |
| NP After MI And SOA Margin (%) | 13.04 | 9.09 | 5.23 | 8.36 | 9.62 |
| Return on Networth / Equity (%) | 16.56 | 13.64 | 8.92 | 14.24 | 18.81 |
| Return on Capital Employeed (%) | 26.60 | 22.62 | 15.54 | 21.43 | 30.91 |
| Return On Assets (%) | 12.30 | 9.59 | 6.28 | 8.50 | 10.51 |
| Asset Turnover Ratio (%) | 1.00 | 0.98 | 1.02 | 0.92 | 1.00 |
| Current Ratio (X) | 4.01 | 3.14 | 2.71 | 1.92 | 1.67 |
| Quick Ratio (X) | 3.27 | 2.41 | 1.87 | 1.33 | 1.11 |
| Inventory Turnover Ratio (X) | 2.26 | 2.14 | 2.25 | 2.07 | 2.12 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 11.21 | 4.86 | 3.31 | 2.90 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 6.12 | 1.90 | 1.99 | 1.95 |
| Earning Retention Ratio (%) | 0.00 | 88.79 | 95.14 | 96.69 | 97.10 |
| Cash Earning Retention Ratio (%) | 0.00 | 93.88 | 98.10 | 98.01 | 98.05 |
| Interest Coverage Ratio (X) | 0.00 | 0.00 | 2707.05 | 58.75 | 569.16 |
| Interest Coverage Ratio (Post Tax) (X) | 0.00 | 0.00 | 779.53 | 26.39 | 271.76 |
| Enterprise Value (Cr.) | 210.89 | 92.31 | 144.85 | 65.34 | 77.58 |
| EV / Net Operating Revenue (X) | 1.89 | 0.84 | 1.32 | 0.64 | 0.77 |
| EV / EBITDA (X) | 6.87 | 3.46 | 7.21 | 3.23 | 3.38 |
| MarketCap / Net Operating Revenue (X) | 2.23 | 1.04 | 1.39 | 0.75 | 0.85 |
| Retention Ratios (%) | 0.00 | 88.78 | 95.13 | 96.68 | 97.09 |
| Price / BV (X) | 2.83 | 1.56 | 2.38 | 1.29 | 1.68 |
| Price / Net Operating Revenue (X) | 2.23 | 1.04 | 1.39 | 0.75 | 0.85 |
| EarningsYield | 0.05 | 0.08 | 0.03 | 0.11 | 0.11 |
After reviewing the key financial ratios for Morganite Crucible (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 17, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 16) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 17, the value is 51.87. This value is within the healthy range. It has increased from 35.67 (Mar 16) to 51.87, marking an increase of 16.20.
- For Diluted EPS (Rs.), as of Mar 17, the value is 51.87. This value is within the healthy range. It has increased from 35.67 (Mar 16) to 51.87, marking an increase of 16.20.
- For Cash EPS (Rs.), as of Mar 17, the value is 75.38. This value is within the healthy range. It has increased from 66.81 (Mar 16) to 75.38, marking an increase of 8.57.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 343.51. It has increased from 285.76 (Mar 16) to 343.51, marking an increase of 57.75.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 343.51. It has increased from 285.76 (Mar 16) to 343.51, marking an increase of 57.75.
- For Revenue From Operations / Share (Rs.), as of Mar 17, the value is 397.75. It has increased from 392.35 (Mar 16) to 397.75, marking an increase of 5.40.
- For PBDIT / Share (Rs.), as of Mar 17, the value is 109.55. This value is within the healthy range. It has increased from 95.26 (Mar 16) to 109.55, marking an increase of 14.29.
- For PBIT / Share (Rs.), as of Mar 17, the value is 91.91. This value is within the healthy range. It has increased from 65.59 (Mar 16) to 91.91, marking an increase of 26.32.
- For PBT / Share (Rs.), as of Mar 17, the value is 91.91. This value is within the healthy range. It has increased from 65.59 (Mar 16) to 91.91, marking an increase of 26.32.
- For Net Profit / Share (Rs.), as of Mar 17, the value is 57.74. This value is within the healthy range. It has increased from 37.14 (Mar 16) to 57.74, marking an increase of 20.60.
- For NP After MI And SOA / Share (Rs.), as of Mar 17, the value is 51.87. This value is within the healthy range. It has increased from 35.67 (Mar 16) to 51.87, marking an increase of 16.20.
- For PBDIT Margin (%), as of Mar 17, the value is 27.54. This value is within the healthy range. It has increased from 24.28 (Mar 16) to 27.54, marking an increase of 3.26.
- For PBIT Margin (%), as of Mar 17, the value is 23.10. This value exceeds the healthy maximum of 20. It has increased from 16.71 (Mar 16) to 23.10, marking an increase of 6.39.
- For PBT Margin (%), as of Mar 17, the value is 23.10. This value is within the healthy range. It has increased from 16.71 (Mar 16) to 23.10, marking an increase of 6.39.
- For Net Profit Margin (%), as of Mar 17, the value is 14.51. This value exceeds the healthy maximum of 10. It has increased from 9.46 (Mar 16) to 14.51, marking an increase of 5.05.
- For NP After MI And SOA Margin (%), as of Mar 17, the value is 13.04. This value is within the healthy range. It has increased from 9.09 (Mar 16) to 13.04, marking an increase of 3.95.
- For Return on Networth / Equity (%), as of Mar 17, the value is 16.56. This value is within the healthy range. It has increased from 13.64 (Mar 16) to 16.56, marking an increase of 2.92.
- For Return on Capital Employeed (%), as of Mar 17, the value is 26.60. This value is within the healthy range. It has increased from 22.62 (Mar 16) to 26.60, marking an increase of 3.98.
- For Return On Assets (%), as of Mar 17, the value is 12.30. This value is within the healthy range. It has increased from 9.59 (Mar 16) to 12.30, marking an increase of 2.71.
- For Asset Turnover Ratio (%), as of Mar 17, the value is 1.00. It has increased from 0.98 (Mar 16) to 1.00, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 17, the value is 4.01. This value exceeds the healthy maximum of 3. It has increased from 3.14 (Mar 16) to 4.01, marking an increase of 0.87.
- For Quick Ratio (X), as of Mar 17, the value is 3.27. This value exceeds the healthy maximum of 2. It has increased from 2.41 (Mar 16) to 3.27, marking an increase of 0.86.
- For Inventory Turnover Ratio (X), as of Mar 17, the value is 2.26. This value is below the healthy minimum of 4. It has increased from 2.14 (Mar 16) to 2.26, marking an increase of 0.12.
- For Dividend Payout Ratio (NP) (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 11.21 (Mar 16) to 0.00, marking a decrease of 11.21.
- For Dividend Payout Ratio (CP) (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 6.12 (Mar 16) to 0.00, marking a decrease of 6.12.
- For Earning Retention Ratio (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 88.79 (Mar 16) to 0.00, marking a decrease of 88.79.
- For Cash Earning Retention Ratio (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 93.88 (Mar 16) to 0.00, marking a decrease of 93.88.
- For Interest Coverage Ratio (X), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 16) which recorded 0.00.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 16) which recorded 0.00.
- For Enterprise Value (Cr.), as of Mar 17, the value is 210.89. It has increased from 92.31 (Mar 16) to 210.89, marking an increase of 118.58.
- For EV / Net Operating Revenue (X), as of Mar 17, the value is 1.89. This value is within the healthy range. It has increased from 0.84 (Mar 16) to 1.89, marking an increase of 1.05.
- For EV / EBITDA (X), as of Mar 17, the value is 6.87. This value is within the healthy range. It has increased from 3.46 (Mar 16) to 6.87, marking an increase of 3.41.
- For MarketCap / Net Operating Revenue (X), as of Mar 17, the value is 2.23. This value is within the healthy range. It has increased from 1.04 (Mar 16) to 2.23, marking an increase of 1.19.
- For Retention Ratios (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 88.78 (Mar 16) to 0.00, marking a decrease of 88.78.
- For Price / BV (X), as of Mar 17, the value is 2.83. This value is within the healthy range. It has increased from 1.56 (Mar 16) to 2.83, marking an increase of 1.27.
- For Price / Net Operating Revenue (X), as of Mar 17, the value is 2.23. This value is within the healthy range. It has increased from 1.04 (Mar 16) to 2.23, marking an increase of 1.19.
- For EarningsYield, as of Mar 17, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 16) to 0.05, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Morganite Crucible (India) Ltd:
- Net Profit Margin: 14.51%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 26.6% (Industry Average ROCE: 18.1%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.56% (Industry Average ROE: 13.55%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 34.2 (Industry average Stock P/E: 36.3)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 14.51%
FAQ
What is the intrinsic value of Morganite Crucible (India) Ltd?
Morganite Crucible (India) Ltd's intrinsic value (as of 06 December 2025) is 1461.84 which is 5.32% lower the current market price of 1,544.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 864 Cr. market cap, FY2025-2026 high/low of 1,964/1,170, reserves of ₹133 Cr, and liabilities of 164 Cr.
What is the Market Cap of Morganite Crucible (India) Ltd?
The Market Cap of Morganite Crucible (India) Ltd is 864 Cr..
What is the current Stock Price of Morganite Crucible (India) Ltd as on 06 December 2025?
The current stock price of Morganite Crucible (India) Ltd as on 06 December 2025 is 1,544.
What is the High / Low of Morganite Crucible (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Morganite Crucible (India) Ltd stocks is 1,964/1,170.
What is the Stock P/E of Morganite Crucible (India) Ltd?
The Stock P/E of Morganite Crucible (India) Ltd is 34.2.
What is the Book Value of Morganite Crucible (India) Ltd?
The Book Value of Morganite Crucible (India) Ltd is 242.
What is the Dividend Yield of Morganite Crucible (India) Ltd?
The Dividend Yield of Morganite Crucible (India) Ltd is 3.17 %.
What is the ROCE of Morganite Crucible (India) Ltd?
The ROCE of Morganite Crucible (India) Ltd is 30.4 %.
What is the ROE of Morganite Crucible (India) Ltd?
The ROE of Morganite Crucible (India) Ltd is 21.4 %.
What is the Face Value of Morganite Crucible (India) Ltd?
The Face Value of Morganite Crucible (India) Ltd is 5.00.